Tilray (TSE:TLRY)
TSX:TLRY
TLRY Stock Chart & Stats
C$9.33
-C$0.15(-6.87%)
At close: 4:00 PM EST
C$9.33
-C$0.15(-6.87%)
Day’s Range― - ―
52-Week RangeC$4.85 - C$32.30
Previous CloseN/A
Volume1.39M
Average Volume (3M)506.17K
Market Cap
C$1.09B
Enterprise ValueC$899.16M
Total Cash (Recent Filing)C$219.93M
Total Debt (Recent Filing)C$317.08M
Price to Earnings (P/E)―
Beta2.00
Next Earnings
Jul 29, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.31
Shares Outstanding116,548,660
10 Day Avg. Volume584,611
30 Day Avg. Volume506,167
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.18
Price to Sales (P/S)0.34
P/FCF Ratio-2.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$11.07Price Target Upside18.68% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)-0.66
Revenue Forecast (FY)C$1.19B
Bulls Say, Bears Say
Bulls Say
Beer Acquisition Operational SynergiesAcquiring established beer brands and brewing operations creates an immediate, scaled European footprint and offers meaningful cost savings potential through operational synergies versus peers.
European Medical Cannabis ExpansionManagement indicated sufficient cultivation capacity in Canada and Portugal to supply growing European medical cannabis demand and expects expansion into markets such as the U.K. and Poland.
Pharmaceutical Segment GrowthAnalyst notes CC Pharma is accelerating growth, improving margins, and expanding relationships with pharmacies and pharmaceutical companies, strengthening the company's healthcare distribution profile.
Bears Say
Acquisition And Integration RiskRepeated acquisition-driven growth has created integration and operational challenges, and the acquired beer business's history of losses complicates efforts to restore profitability.
Aluminum Cost ExposureRising aluminum costs and heavy use of cans are reducing beverage gross margins and increase vulnerability to raw-material price swings and supply disruptions.
Beverage Distribution And Shelf Space LossProduct lineup rationalization and loss of shelf space for some acquired brands have reduced beverage distribution and volumes, weighing on revenue.
Tilray News
TLRY FAQ
What was Tilray’s price range in the past 12 months?
Tilray lowest stock price was C$4.85 and its highest was C$32.30 in the past 12 months.
What is Tilray’s market cap?
Tilray’s market cap is C$1.09B.
When is Tilray’s upcoming earnings report date?
Tilray’s upcoming earnings report date is Jul 29, 2026 which is in 111 days.
How were Tilray’s earnings last quarter?
Tilray released its earnings results on Apr 01, 2026. The company reported -C$0.31 earnings per share for the quarter, missing the consensus estimate of -C$0.188 by -C$0.122.
Is Tilray overvalued?
According to Wall Street analysts Tilray’s price is currently Undervalued.
Does Tilray pay dividends?
Tilray does not currently pay dividends.
What is Tilray’s EPS estimate?
Tilray’s EPS estimate is -0.01.
How many shares outstanding does Tilray have?
Tilray has 116,548,660 shares outstanding.
What happened to Tilray’s price movement after its last earnings report?
Tilray reported an EPS of -C$0.31 in its last earnings report, missing expectations of -C$0.188. Following the earnings report the stock price went down -4.571%.
Which hedge fund is a major shareholder of Tilray?
Currently, no hedge funds are holding shares in TSE:TLRY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Tilray Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$11.07 (18.68% Upside)
C$11.07 (18.68% Upside)
Blogger Sentiment
Neutral
TSE:TLRY Sentiment 50%
Sector Average ―
Sector Average ―
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.8%
Last 30 Days ▼ 1.8%
Last 30 Days ▼ 1.8%
News Sentiment
Bearish
Bullish news 25%
Bearish news 75%
Bearish news 75%
Technicals
SMA
Negative
20 days / 200 days
Momentum
12.46%
12-Months-Change
Fundamentals
Return on Equity
-92.34%
Trailing 12-Months
Asset Growth
-39.04%
Trailing 12-Months
Company Description
Tilray
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
TLRY Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted clear operational progress: record quarterly revenue, strong international cannabis momentum, meaningful distribution growth, completed cost-savings programs and strategic beverage partnerships/acquisition that materially expand the company’s scale. Several significant challenges remain — beverage revenue and margin pressure, input cost volatility (aluminum, fuel), working capital-related cash use, regulatory uncertainty in the U.S., and integration work for BrewDog — but management presented concrete actions (hedging, Project 420, SKU rationalization, partnerships) and a strengthened liquidity position. On balance, the positive operational and strategic developments outweigh the near-term headwinds.View all TSE:TLRY earnings summariesTLRY Stock 12 Month Forecast
Average Price Target
C$11.07
▲(18.68% Upside)
Technical Analysis
Options Prices
Currently, No data available
---